Transportation Assistance for Cancer Care
(TRACT Trial)
Trial Summary
What is the purpose of this trial?
This clinical trial evaluates whether the Transportation for Cancer Care Navigation Tool (TRACT) can reduce travel barriers among patients with solid tumors receiving radiation therapy. It is estimated that 20-30% patients with cancer experience travel-related barriers for cancer care. This is a particular problem for patients with radiation therapy as these patients frequently receive multiple treatment cycles, which often require daily treatment for multiple weeks or months. Addressing travel barriers has been a prerequisite for cancer care as travel barriers negatively influence cancer treatment adherence and cancer care outcomes, such as survival and quality of life. The TRACT program may help reduce travel barriers and therefore promote health equity among patients with solid tumors receiving radiation therapy.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on addressing travel barriers for cancer care.
What data supports the effectiveness of the treatment Transportation for Cancer Care Navigation Tool (TRACT)?
Research on patient navigation programs, which help guide cancer patients through treatment, shows they can improve therapy management, adherence to treatment, and quality of life. These programs often address barriers like transportation, suggesting that TRACT could be effective in helping patients access cancer care.12345
Is the Transportation Assistance for Cancer Care program safe for humans?
How does the transportation assistance treatment for cancer care differ from other treatments?
The transportation assistance treatment for cancer care is unique because it focuses on providing logistical support, such as transportation, to help patients access their cancer treatments. This approach is different from traditional medical treatments as it addresses practical barriers to care, improving adherence and reducing stress for patients.12589
Research Team
Jinbing Bai
Principal Investigator
Emory University Hospital/Winship Cancer Institute
Eligibility Criteria
This trial is for patients with solid tumors who are undergoing radiation therapy and face travel barriers to receive their treatment. It aims to help those who struggle with getting to their appointments due to transportation issues.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Stage I (CAB)
Participants meet with the study research team to develop and refine the TRACT program
Stage II (Treatment)
Patients receive either the TRACT program or usual care with PAF pamphlet for 3 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Transportation for Cancer Care Navigation Tool (TRACT)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor
National Cancer Institute (NCI)
Collaborator